Enose-Akahata, Yoshimi <br/><br/>
Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease.  [electronic resource] 

 -  Retrovirology  Feb 2012 
 - 16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1742-4690 
<br/><br/><label>Standard No.: </label>10.1186/1742-4690-9-16  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Viral--immunology<br/>Cells, Cultured<br/>Human T-lymphotropic virus 1--immunology<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Interleukin-1beta--antagonists & inhibitors<br/>Lipopolysaccharide Receptors--analysis<br/>Minocycline--administration & dosage<br/>Paraparesis, Tropical Spastic--drug therapy<br/>Phagocytes--chemistry<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors